These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 36992474)
1. Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Filippatos C; Ntanasis-Stathopoulos I; Sekeri K; Ntanasis-Stathopoulos A; Gavriatopoulou M; Psaltopoulou T; Dounias G; Sergentanis TN; Terpos E Viruses; 2023 Mar; 15(3):. PubMed ID: 36992474 [No Abstract] [Full Text] [Related]
2. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747 [TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959 [TBL] [Abstract][Full Text] [Related]
4. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Ling RR; Sim JJL; Tan FL; Tai BC; Syn N; Mucheli SS; Fan BE; Mitra S; Ramanathan K Transfus Med Rev; 2022 Jan; 36(1):16-26. PubMed ID: 34782209 [TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ Trials; 2021 May; 22(1):342. PubMed ID: 34001174 [TBL] [Abstract][Full Text] [Related]
8. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. Janiaud P; Axfors C; Schmitt AM; Gloy V; Ebrahimi F; Hepprich M; Smith ER; Haber NA; Khanna N; Moher D; Goodman SN; Ioannidis JPA; Hemkens LG JAMA; 2021 Mar; 325(12):1185-1195. PubMed ID: 33635310 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis. Senefeld JW; Franchini M; Mengoli C; Cruciani M; Zani M; Gorman EK; Focosi D; Casadevall A; Joyner MJ JAMA Netw Open; 2023 Jan; 6(1):e2250647. PubMed ID: 36633846 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis. Kim MS; An MH; Kim WJ; Hwang TH PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357 [TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research. Gupta T; Kannan S; Kalra B; Thakkar P Transfus Med; 2021 Dec; 31(6):409-420. PubMed ID: 34189780 [TBL] [Abstract][Full Text] [Related]
12. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T; Trials; 2021 May; 22(1):343. PubMed ID: 34001215 [TBL] [Abstract][Full Text] [Related]
13. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671 [TBL] [Abstract][Full Text] [Related]
14. CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence. Kloypan C; Saesong M; Sangsuemoon J; Chantharit P; Mongkhon P Eur J Clin Invest; 2021 Nov; 51(11):e13663. PubMed ID: 34375445 [TBL] [Abstract][Full Text] [Related]
15. Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis. Mihalek N; Radovanović D; Barak O; Čolović P; Huber M; Erdoes G Sci Rep; 2023 Aug; 13(1):12904. PubMed ID: 37558729 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis. Devasenapathy N; Ye Z; Loeb M; Fang F; Najafabadi BT; Xiao Y; Couban R; Bégin P; Guyatt G CMAJ; 2020 Jul; 192(27):E745-E755. PubMed ID: 32444482 [TBL] [Abstract][Full Text] [Related]
17. Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression. Snow TAC; Saleem N; Ambler G; Nastouli E; McCoy LE; Singer M; Arulkumaran N Br J Anaesth; 2021 Dec; 127(6):834-844. PubMed ID: 34579942 [TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma may not be an effective treatment for severe and critically ill covid-19 patients: A Systematic Review & Meta-Analysis of Randomized Controlled Trials. Yang P; Wang J; Zheng R; Tan R; Li X; Liu X; Li Y; Yuan Z; Wang Y; Chen Q; Yu J Heart Lung; 2022; 53():51-60. PubMed ID: 35149308 [TBL] [Abstract][Full Text] [Related]